Bone cement 1
DeviceBone cement SmartSet® HV
Other names: SmartSet HV
NCT Number: NCT00837850
A randomised radiostereometric study comparing SmartSet HV and Palacos R acrylic bone cements.
Looking for future studies?
Notify Me18 year–78 year
All sexes
Interventional
Not applicable
The fixation of components in total hip arthroplasty has a significant effect on the long-term survival of the prostheses. Bone cement in total joint replacement acts as an anchoring medium for the prosthesis and provides a barrier to the ingress of wear debris into bone surfaces. However, there are significant differences in cement behaviour among differing types of cement. A clinical study based on the Norwegian Arthroplasty Register demonstrated that there is an increased rate of revision due to aseptic loosening of femoral components implanted with low-viscosity cement compared with that of high-viscosity.
Studies have shown that high early migration for certain designs of femoral prosthesis can be a predictor for clinical loosening. RSA is a technique enabling calculation of the three-dimensional translational and rotational movements of the implant relative to the bone, and therefore provides an ideal technique to detect early micromotion of implants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bone cement SmartSet® HV
Other names: SmartSet HV
Bone cement Palacos R
Other names: Palacos R
Time frame: 2010
Time frame: 2010
Norwegian University of Science and Technology
Other
A Randomised Prospective Trial of SmartSet HV and Palacos R Bone Cements in Primary Total Hip Arthroplasty. A Radiostereometric Analysis of the Charnley Femoral Component.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01387100
Arthritis, Joint Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial DetailsNCT06257537
Arthritis, Joint Diseases
Stamford, Connecticut, United States
View Trial DetailsNCT01867840
Arthritis, Arthritis, Gouty
Nice, France
View Trial Details